02 Aug 2007 Iomai Vaccine Confers Statistically Significant Protection Against Travelers' Diarrhea in Phase 2 Study
01 Aug 2007 Novavax Begins Human Clinical Testing of Novel Pandemic Flu Vaccine
31 Jul 2007 AVANT Commences Phase 2 Clinical Trial of Its Single Dose, Oral Typhoid Fever Vaccine
31 Jul 2007 Alphavax announces interim results from Phase 1 influenza vaccine clinical trial
26 Jul 2007 Oxford Biomedica announces data safety monitoring board recommendation to continue TroVax (R) Phase III trial in renal cancer as planned
24 Jul 2007 Nventa announces publication of final results of Phase 2 study of hspe7 un Cervical Dysplasia
24 Jul 2007 IDM Pharma Announces Plans to Amend New Drug Application for Mifamurtide (L-MTP-PE) for the Treatment of Patients with Osteosarcoma
24 Jul 2007 Baxter Announces Preliminary Phase I/II Data for Seasonal Influenza Vaccine Candidate
20 Jul 2007 Affiris begins clinical testing of Alzheimer's vaccine
19 Jul 2007 Orchestra Therapeutics discontinues its HIV vaccine development program
19 Jul 2007 Publication of VIR201 Phase IIa trial results in peer reviewed scientific journal
19 Jul 2007 TechnoVax Reports on a VLP Vaccine Designed to Protect Against the Devastating 1918 Pandemic Influenza As Well As a Novel Bivalent VLP Vaccine Candidate
18 Jul 2007 Acambis' universal influenza vaccine enters Phase 1 trial
18 Jul 2007 GeoVax Announces Start of 2 New HIV/AIDS Vaccine Human Trials
13 Jul 2007 Dynavax Completes Enrollment of HEPLISAV(TM) Phase 3
12 Jul 2007 Geron initiates clinical trial of Telomerase cancer vaccine in patients with acute myelogenous leukemia
12 Jul 2007 Clinical Development Update
11 Jul 2007 Cell Genesys Completes Patient Recruitment for First Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
10 Jul 2007 Novavax Licenses Wyeth's Virus-Like Particle Technology
04 Jul 2007 Cytos Biotechnology reports results from phase IIa study with CYT003-QbG10 in patients suffering from atopic dermatitis
04 Jul 2007 MedImmune Begins Dosing Children Six Months to 24 Months of Age in Phase 1 Study of Vaccine to Help Prevent Two of the Most Common Viral Causes of Childhood Respiratory Illness
03 Jul 2007 Novartis enhances its vaccine pipeline by gaining access to Intercell's key technologies and vaccines programs
03 Jul 2007 DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC(TM)
28 Jun 2007 AVANT's Partner, GlaxoSmithKline, Files Rotarix(R) Application for U.S. Marketing Approval with the FDA
27 Jun 2007 Dynavax Starts HEPLISAV(TM) Phase 3 in Europe; U.S. Study; and Phase 2 in ESRD in Canada

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up